Designer Babies
By Sharon Begley,
Newsweek
| 11. 09. 1998
It is only a matter of time. One day--a day probably no more distant than the first wedding anniversary of a couple who are now teenage sweethearts--a man and a woman will walk into an in vitro fertilization clinic and make scientific history. Their problem won't be infertility, the reason couples now choose IVF. Rather, they will be desperate for a very special child, a child who will elude a family curse. To create their dream child, doctors will fertilize a few of the woman's eggs with her husband's sperm, as IVF clinics do today. But then they will inject an artificial human chromosome, carrying made-to-order genes like pearls on a string, into the fertilized egg. One of the genes will carry instructions ordering cells to commit suicide. Then the doctors will place the embryo into the woman's uterus. If her baby is a boy, when he becomes an old man he, like his father and grandfather before him, will develop prostate cancer. But the cell-suicide gene will make his prostate cells self-destruct. The man, unlike his ancestors, will not...
Related Articles
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...
By Antonia O'Flaherty, ABC News Australia | 03.04.2026
Fertility giant Monash IVF has agreed to pay financial settlements to families involved in two major bungles that saw two women transferred the wrong embryo.
In February 2025 the company became aware that one of its Brisbane clinic's patients had...
By Dr. Marcin Śmietana, Progress Educational Trust (PET) | 03.02.2026
When a family created through surrogacy abroad returns to their home country after the birth of the child, the genetic parent(s) are usually recognised as legal parents by default. However, any parent without a genetic link to the child needs...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...